Bronte Capital Management Pty
Latest statistics and disclosures from Bronte Capital Management Pty's latest quarterly 13F-HR filing:
- Top 5 stock holdings are REGN, GOOGL, IBKR, Visa Inc-class A Shares, BRK.B, and represent 57.06% of Bronte Capital Management Pty's stock portfolio.
- Added to shares of these 10 stocks: REGN (+$43M), TBBB (+$13M), BBWI, FICO, TPB, NICE, ALNY, OLED, JRVR, GUTS.
- Started 16 new stock positions in TBBB, CHRS, PLRX, IVVD, ALEC, FATE, GUTS, FICO, OLED, CCCC. MIST, RANI, TPB, JRVR, NICE, CRBU.
- Reduced shares in these 10 stocks: IBB (-$35M), COF (-$22M), IBKR (-$18M), ABVX (-$15M), Vaneck Etf Trust (-$14M), IJR (-$13M), Vaneck Etf Trust (-$7.7M), FCNCA (-$7.6M), BRK.B (-$6.2M), IWO (-$6.0M).
- Sold out of its positions in ABVX, IWO, IJR.
- Bronte Capital Management Pty was a net seller of stock by $-97M.
- Bronte Capital Management Pty has $1.0B in assets under management (AUM), dropping by -10.22%.
- Central Index Key (CIK): 0001471085
Tip: Access up to 7 years of quarterly data
Positions held by Bronte Capital Management Pty consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bronte Capital Management Pty
Bronte Capital Management Pty holds 43 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | 18.2 | $182M | +30% | 236k | 771.87 |
|
| Alphabet Cap Stk Cl A (GOOGL) | 13.0 | $130M | -2% | 416k | 313.00 |
|
| Interactive Brokers Group Com Cl A (IBKR) | 9.5 | $96M | -15% | 1.5M | 64.31 |
|
| Visa Inc-class A Shares | 8.2 | $83M | 235k | 350.71 |
|
|
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 8.1 | $82M | -7% | 162k | 502.65 |
|
| Amazon (AMZN) | 6.4 | $64M | -4% | 278k | 230.82 |
|
| Philip Morris International (PM) | 6.4 | $64M | -4% | 399k | 160.40 |
|
| Capital One Financial (COF) | 4.2 | $43M | -33% | 176k | 242.36 |
|
| Corteva (CTVA) | 3.8 | $38M | 569k | 67.03 |
|
|
| First Ctzns Bancshares Inc N Cl A (FCNCA) | 3.7 | $37M | -17% | 17k | 2146.18 |
|
| Vaneck Etf Trust Gold Miners Etf | 1.9 | $19M | -29% | 218k | 85.77 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.5 | $16M | +11% | 39k | 397.65 |
|
| Sotera Health | 1.5 | $15M | 875k | 17.64 |
|
|
| Graham Hldgs Com Cl B (GHC) | 1.5 | $15M | 13k | 1098.60 |
|
|
| Herbalife Nutrition Com Shs (HLF) | 1.4 | $14M | -17% | 1.1M | 12.89 |
|
| Pinterest Cl A (PINS) | 1.3 | $13M | -21% | 512k | 25.89 |
|
| Bbb Foods Cl A Com (TBBB) | 1.3 | $13M | NEW | 394k | 33.39 |
|
| Ishares Tr Ishares Biotech (IBB) | 1.2 | $12M | -74% | 72k | 168.77 |
|
| Sociedad Quimica Y Minera De Spon Adr Ser B (SQM) | 1.1 | $11M | 164k | 68.80 |
|
|
| Sally Beauty Holdings (SBH) | 1.0 | $11M | -31% | 737k | 14.26 |
|
| Newmont Mining Corporation (NEM) | 0.8 | $7.8M | 78k | 99.85 |
|
|
| Barrick Mng Corp Com Shs (B) | 0.7 | $7.2M | -22% | 165k | 43.55 |
|
| Liveramp Holdings (RAMP) | 0.7 | $6.8M | 232k | 29.37 |
|
|
| Bath & Body Works In (BBWI) | 0.5 | $5.1M | +121% | 255k | 20.08 |
|
| Mondelez Intl Cl A (MDLZ) | 0.3 | $3.5M | -2% | 65k | 53.83 |
|
| Vaneck Etf Trust Junior Gold Mine | 0.3 | $3.2M | -81% | 28k | 113.78 |
|
| Fair Isaac Corporation (FICO) | 0.3 | $2.6M | NEW | 1.6k | 1690.62 |
|
| Turning Pt Brands (TPB) | 0.3 | $2.6M | NEW | 24k | 108.40 |
|
| Riskified Shs Cl A (RSKD) | 0.3 | $2.6M | 514k | 4.97 |
|
|
| Nice Sponsored Adr (NICE) | 0.2 | $2.3M | NEW | 20k | 113.04 |
|
| Universal Display Corporation (OLED) | 0.1 | $1.4M | NEW | 12k | 116.78 |
|
| James Riv Group Holdings Com Shs (JRVR) | 0.1 | $786k | NEW | 124k | 6.36 |
|
| Enovix Corp (ENVX) | 0.0 | $84k | 12k | 7.31 |
|
|
| Fractyl Health (GUTS) | 0.0 | $37k | NEW | 17k | 2.20 |
|
| Alector (ALEC) | 0.0 | $30k | NEW | 19k | 1.56 |
|
| Coherus Biosciences (CHRS) | 0.0 | $27k | NEW | 19k | 1.42 |
|
| Adagio Therapeutics (IVVD) | 0.0 | $27k | NEW | 11k | 2.47 |
|
| Caribou Biosciences (CRBU) | 0.0 | $25k | NEW | 16k | 1.59 |
|
| Pliant Therapeutics (PLRX) | 0.0 | $23k | NEW | 19k | 1.22 |
|
| Fate Therapeutics (FATE) | 0.0 | $23k | NEW | 23k | 0.98 |
|
| Milestone Pharmaceuticals (MIST) | 0.0 | $21k | NEW | 10k | 2.02 |
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.0 | $20k | NEW | 15k | 1.35 |
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $19k | NEW | 10k | 1.91 |
|
Past Filings by Bronte Capital Management Pty
SEC 13F filings are viewable for Bronte Capital Management Pty going back to 2018
- Bronte Capital Management Pty 2025 Q4 filed Feb. 3, 2026
- Bronte Capital Management Pty 2025 Q3 filed Nov. 5, 2025
- Bronte Capital Management Pty 2025 Q2 filed Aug. 12, 2025
- Bronte Capital Management Pty 2025 Q1 filed May 14, 2025
- Bronte Capital Management Pty 2024 Q4 filed Feb. 10, 2025
- Bronte Capital Management Pty 2024 Q3 filed Nov. 5, 2024
- Bronte Capital Management Pty 2024 Q2 filed Aug. 7, 2024
- Bronte Capital Management Pty 2024 Q1 filed May 13, 2024
- Bronte Capital Management Pty 2023 Q4 filed Feb. 7, 2024
- Bronte Capital Management Pty 2023 Q3 filed Nov. 6, 2023
- Bronte Capital Management Pty 2023 Q2 filed Aug. 8, 2023
- Bronte Capital Management Pty 2023 Q1 filed May 12, 2023
- Bronte Capital Management Pty 2022 Q4 filed Feb. 14, 2023
- Bronte Capital Management Pty 2022 Q3 filed Nov. 3, 2022
- Bronte Capital Management Pty 2022 Q2 filed Aug. 8, 2022
- Bronte Capital Management Pty 2022 Q2 restated filed Aug. 8, 2022